(Q33863319)

29 July 2017

title

Karyotypic "state" as a potential determinant for anticancer drug discovery (English)

1 reference

29 July 2017

0 references

1 reference

Kimberly Bussey

5

0 references

author name string

Anna V Roschke

1

1 reference

29 July 2017

Samir Lababidi

2

1 reference

29 July 2017

Giovanni Tonon

3

1 reference

29 July 2017

Kristen S Gehlhaus

4

1 reference

29 July 2017

John N Weinstein

6

1 reference

29 July 2017

Ilan R Kirsch

7

1 reference

29 July 2017

language of work or name

English

0 references

publication date

9 February 2005

1 reference

Proceedings of the National Academy of Sciences of the United States of America

29 July 2017

published in

1 reference

29 July 2017

volume

102

1 reference

29 July 2017

issue

8

1 reference

29 July 2017

page(s)

2964-2969

1 reference

describes a project that uses

29 July 2017

KM20L2

0 references

cites work

Vascular targeting agents as cancer therapeutics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549443

Opportunities and challenges in the development of kinase inhibitor therapy for cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549443

Combretastatins: from natural products to drug discovery

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549443

Karyotypic complexity of the NCI-60 drug-screening panel.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549443

A rhodium(III) complex for high-affinity DNA base-pair mismatch recognition

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549443

A phase I trial of depsipeptide (FR901228) in patients with advanced cancer.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549443

Perspectives on the development of a molecularly targeted agent

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549443

Phase I trial of the histone deacetylase inhibitor, depsipeptide (FR901228, NSC 630176), in patients with refractory neoplasms

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549443

Cytotoxicity and mutagenicity of frameshift-inducing agent ICR191 in mismatch repair-deficient colon cancer cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549443

A gene expression database for the molecular pharmacology of cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549443

Genomic changes defining the genesis, progression, and malignancy potential in solid human tumors: a phenotype/genotype correlation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549443

The NCI anti-cancer drug screen: a smart screen to identify effectors of novel targets

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549443

Clinical significance of cytogenetic findings in solid tumors

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549443

An information-intensive approach to the molecular pharmacology of cancer.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549443

Multimodal action of antitumor agents on DNA: the ellipticine series

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549443

Effects of cytochalasin and phalloidin on actin

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549443

Development of human tumor cell line panels for use in disease-oriented drug screening

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549443

Morphological and immunocytochemical characteristics of human tumor cell lines for use in a disease-oriented anticancer drug screen

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549443

Intercalative binding of ellipticine to DNA

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549443

The chromosomal basis of human neoplasia.

5 July 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0405578102

Shaping of tumor and drug-resistant genomes by instability and selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0405578102

Mining the National Cancer Institute Anticancer Drug Discovery Database: cluster analysis of ellipticine analogs with p53-inverse and central nervous system-selective patterns of activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0405578102

Rescue of mutant p53 transcription function by ellipticine

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0405578102

Combretastatin A-1 phosphate a novel tubulin-binding agent with in vivo anti vascular effects in experimental tumours

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549443

Gateways to clinical trials

29 October 2018

1 reference

12 December 2020

Tumor karyotype predicts clinical outcome in colorectal cancer patients

1 reference

12 December 2020

Structure of cytochalasins and cytochalasin B binding sites in human erythrocyte membranes

1 reference

12 December 2020

Cytogenetic aberrations in colorectal adenocarcinomas and their correlation with clinicopathologic features

1 reference

12 December 2020

Karyotypic pattern of pancreatic adenocarcinomas correlates with survival and tumour grade

1 reference

12 December 2020

Correlation between karyotypic pattern and clincopathologic features in 125 breast cancer cases

1 reference

12 December 2020

Identifiers

DOI

10.1073/PNAS.0405578102

1 reference

29 July 2017

0 references

1 reference

29 July 2017

1 reference